NCT07428616
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07428616
Title A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Exelixis
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Exelixis Site #3 RECRUITING Miami Florida 33176 United States Details
Exelixis Site #2 RECRUITING Houston Texas 77030 United States Details
Exelixis Site #1 RECRUITING San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field